Factors Associated with Peripheral Blood Stem Cell Yield in Volunteer Donors Mobilized with Granulocyte Colony-Stimulating Factors: The Impact of Donor Characteristics and Procedural Settings

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 11, 2008, Pages 1305-1311

  Wang, Tso Fu ^a   Wen, Shu Hui ^b   Chen, Rong Long ^a   Lu, Chi Jui ^c   Zheng, Ya Jun ^a   Yang, Shang Hsien ^a   Chu, Sung Chao ^a   Kao, Ruey Ho ^a,b   Chen, Shu Huey ^a,b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c Buddhist Tzu Chi Stem Cells Center   (Taiwan)

Author keywords

Apheresis; Granulocyte colony stimulating factor; Healthy donor; Hematopoietic stem cell mobilization

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; APHERESIS; ARTICLE; BODY MASS; BONE PAIN; CELL COUNT; DONOR; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; FLOW RATE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INSOMNIA; LEUKOCYTE; MALE; NAUSEA; PERIPHERAL BLOOD STEM CELL; RADIAL ARTERY; SEX DIFFERENCE; STEM CELL MOBILIZATION; VASCULAR ACCESS;

ADULT; ANTIGENS, CD34; BODY MASS INDEX; CELL SEPARATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; LIVING DONORS; MALE; SEX CHARACTERISTICS; SEX FACTORS;

EID: 53749099230     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.09.002     Document Type: Article

References (23)

1. Korbling M., Przepiorka D., Huh Y.O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85 (1995) 1659-1665
2. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344 (2001) 175-181
3. Tricot G., Jagannath S., Vesole D., et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85 (1995) 588-596
4. Stockerl-Goldstein K.E., Reddy S.A., Horning S.F., et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant 6 (2000) 506-512
5. Takeyama K., and Ohto H. PBSC mobilization. Transfus Apher Sci 31 (2004) 233-243
6. Confer D.L., and Miller J.P. Optimal donor selection: beyond HLA. Biol Blood Marrow Transplant 13 (2007) 83-86
7. Leuner S., Arland M., Kahl C., et al. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy. Bone Marrow Transplant 22 (1998) 699-706
8. + cells in normal donors treated with filgrastim. Transfusion 37 (1997) 507-512
9. de la Rubia J., Arbona C., de Arriba F., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 42 (2002) 4-9
10. Diaz M.A., Sevilla J., de la Rubia J., et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica 88 (2003) 919-922
11. + cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion 44 (2004) 526-532
12. Ikeda K., Kozuka T., and Harada M. Factors for PBPC collection efficiency and collection predictors. Transfus Apher Sci 31 (2004) 245-259
13. Lysak D., Koza V., and Jindra P. Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apher Sci 33 (2005) 275-283
14. Suzuya H., Watanabe T., Nakagawa R., et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 89 (2005) 229-235
15. Ings S.J., Balsa C., Leverett D., et al. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 134 (2006) 517-525
16. Vasu S., Leitman S.F., Tisdale J.F., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 112 (2008) 2092-100
17. Engelhardt M., Bertz H., Afting M., et al. High- versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral blood progenitor cells from allogeneic donors and CD34(+) immunoselection. J Clin Oncol 17 (1999) 2160-2172
18. Fischer J.C., Frick M., Wassmuth R., et al. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. Br J Haematol 130 (2005) 740-746
19. + cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 43 (2003) 622-625
20. Gazitt Y., Freytes C.O., Callander N., et al. Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J Hematother 8 (1999) 173-183
21. Watanabe T., Kajiume T., Takaue Y., et al. Decrease in circulating hematopoietic progenitor cells by trapping in the pulmonary circulation. Cytotherapy 3 (2001) 461-466
22. Lie A.K., Hui C.H., Rawling T., et al. Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF. Bone Marrow Transplant 22 (1998) 853-857
23. Kroger N., Renges H., Kruger W., et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 111 (2000) 761-765